Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
- Resource Type
- Authors
- Peter J. Frederick; John Kasznica; Rachel Brightwell; K.S. Grzankowski
- Source
- Gynecologic Oncology Reports, Vol 14, Iss C, Pp 6-8 (2015)
Gynecologic Oncology Reports
- Subject
- Pathology
medicine.medical_specialty
Stromal cell
endocrine system diseases
Heterologous
Case Report
lcsh:Gynecology and obstetrics
lcsh:RC254-282
chemistry.chemical_compound
Text mining
Sertoli–Leydig
Medicine
Favorable outcome
neoplasms
lcsh:RG1-991
Taxane
business.industry
Poorly differentiated
organic chemicals
Obstetrics and Gynecology
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Carboplatin
female genital diseases and pregnancy complications
Sarcomatoid
Sarcomatoid Features
Oncology
chemistry
Ovarian
Cancer research
business
therapeutics
- Language
- English
- ISSN
- 2352-5789
Highlights • Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe. • FOXL2 mutations account for approximately 50% of these tumors. • Carboplatin and taxane may afford a favorable outcome.